¼¼°èÀÇ ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼ú ½ÃÀå : Á¦Ç° À¯Çüº°, ÇÁ·Î¼¼½º À¯Çüº°, ¼¼Æ÷ À¯Çüº°, ±Ô¸ðº°, ¿ëµµº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, Á¡À¯À², ¿¹Ãø(2025-2032³â)
Bioprocess Technology Market, By Product Type, By Process Type, By Cell Type, By Scale, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
»óǰÄÚµå : 1756414
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 260 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,474,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,401,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,778,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼ú ½ÃÀå ±Ô¸ð´Â 2024³â 307¾ï 1,032¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2025-2032³â ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 14.90%·Î È®´ëµÉ Àü¸ÁÀÔ´Ï´Ù.

¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼ú ½ÃÀå ¿ªÇÐ

ÀÏȸ¿ë ±â¼ú ¹× ÀÚµ¿È­ ±â¼úÀÇ Áøº¸°¡ ½ÃÀå ¼ºÀåÀ» °¡¼Ó

ÀÏȸ¿ë ±â¼ú ¹× ÀÚµ¿È­ ±â¼úÀÇ ¹ßÀüÀº ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º¸¦ º¯È­½Ã۰í ÀÖÀ¸¸ç, FDA¿Í NIH¿Í °°Àº Á¶Á÷Àº Á¦Á¶ À¯¿¬¼ºÀ» ³ôÀÌ°í ¿À¿° À§ÇèÀ» ÁÙÀÌ´Â ¿ªÇÒÀ» °­Á¶Çϰí ÀÖ½À´Ï´Ù. FDAÀÇ 2022³â °¡À̵å¶óÀÎÀº ÀÏȸ¿ë ½Ã½ºÅÛÀ» ½Å¼ÓÇÑ ½ºÄÉÀϾ÷À» Áö¿øÇÏ°í ±³Â÷ ¿À¿°À» ÃÖ¼ÒÈ­ÇÏ´Â ÃֽŠ»ý¹° Á¦Á¦ Á¦Á¶ÀÇ Áß¿äÇÑ ±¸¼º ¿ä¼Ò·Î °­Á¶Çϰí ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿ÀÀǾàǰÁ¦Á¶Çõ½Å¿¬±¸¼Ò(NIIMBL)ÀÇ º¸°í¼­¿¡ µû¸£¸é ÀÚµ¿È­µÈ ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì Ç÷§ÆûÀº Á¦Á¶ »çÀÌŬ ŸÀÓÀ» ÃÖ´ë 30% ´ÜÃàÇϰí È¿À²¼º°ú Àϰü¼ºÀ» ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ±ÔÁ¦ ±â°ü¿¡ ÀÇÇØ ½ÂÀÎµÈ ¿¬¼Ó ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼úÀº, ƯÈ÷ ¹é½Å Á¦Á¶¿¡ À־, °øÁß º¸°Ç»óÀÇ ±ä±Þ »çÅ¿¡ ´ëÇÑ ½Å¼ÓÇÑ ´ëÀÀÀ» °¡´ÉÇÏ°Ô ÇØ, ÁöÁö¸¦ ¸ðÀ¸°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú ½ÃÇÁÆ®´Â ¾ö°ÝÇÑ Ç°Áú ±âÁØÀÌ Ã¤ÅÃÀ» µÞ¹ÞħÇÏ´Â ¹Ì±¹À̳ª À¯·´°ú °°Àº Áö¿ª¿¡¼­ ƯÈ÷ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÇÑÆí, ½ÅÈï ½ÃÀå¿¡¼­´Â, ÇöÁöÀÇ »ý¹° Á¦Á¦ Á¦Á¶ ´É·ÂÀ» ³ôÀ̱â À§Çؼ­ ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀ» ÅëÇÕÇϱ⠽ÃÀÛÇϰí ÀÖ½À´Ï´Ù.

¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼ú ½ÃÀå : ÁÖ¿ä °í·Á»çÇ×

´ç»çÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®ÀÇ ºÐ¼®¿¡ µû¸£¸é ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2025-2032³â) ¾à 14.90%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

Á¦Ç° À¯Çüº°·Î Àåºñ´Â 2024³â ÃÖ´ë ½ÃÀå Á¡À¯À²À» º¸¿©ÁØ °ÍÀ¸·Î Æò°¡µÇ¾ú½À´Ï´Ù.

ÇÁ·Î¼¼½º À¯Çüº°·Î ¹èÄ¡ 󸮴 2024³â ÁÖ¿ä ÇÁ·Î¼¼½º À¯ÇüÀ̾ú½À´Ï´Ù.

¼¼Æ÷ À¯Çüº°·Î Æ÷À¯·ù ¼¼Æ÷´Â 2024³â ÁÖ¿ä ¼¼Æ÷ À¯ÇüÀ̾ú½À´Ï´Ù.

±Ô¸ðº°·Î´Â 2024³â »ó¾÷ ±Ô¸ð°¡ ÁÖ¿ä ±Ô¸ð°¡ µÇ¾ú½À´Ï´Ù.

¿ëµµº°·Î´Â ´ÜÀÏŬ·ÐÇ×ü »ý»êÀÌ 2024³â ÁÖ¿ä ¿ëµµ¿´½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2024³â ¸ÅÃâ¿¡¼­ ÃÖ°í¸¦ Â÷ÁöÇß½À´Ï´Ù.

¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼ú ½ÃÀå : ¼¼ºÐÈ­ ºÐ¼®

¼¼°èÀÇ ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼ú ½ÃÀåÀº Á¦Ç° À¯Çü, ÇÁ·Î¼¼½º À¯Çü, ¼¼Æ÷ À¯Çü, ±Ô¸ð, ¿ëµµ ¹× Áö¿ª¿¡ µû¶ó ±¸ºÐµË´Ï´Ù.

½ÃÀåÀº Á¦Ç° À¯Çü¿¡ µû¶ó 2°¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ±â±â(¹ÙÀÌ¿À ÇÁ·Î¼¼½º ºÐ¼®±â, °¡½º ºÐ¼®±â, »ïÅõ¾Ð°è, ¼¿ Ä«¿îÅÍ ½Ã½ºÅÛ, ¹ÙÀÌ¿À ¸®¾×ÅÍ, ÀÎÅ¥º£ÀÌÅÍ) ¹× ¼Ò¸ðǰ, ºÎ¼Óǰ(¹èÁö, ½Ã¾à)ÀÔ´Ï´Ù. ¹ÙÀÌ¿À ¸®¾×ÅÍ ¹× ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ºÐ¼®±â´Â ¼ö¿ä¸¦ ¼±µµÇϰí ÀÖÀ¸¸ç ¹è¾ç¾×°ú ½Ã¾àÀ» Æ÷ÇÔÇÑ ¼Ò¸ðǰ ¹× ¾×¼¼¼­¸®´Â ÀÏ»ó ¾÷¹«¸¦ Áö¿øÇÏ°í ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ¿öÅ©Ç÷οìÀÇ ÀϰüµÈ ¼¼Æ÷ Áõ½Ä°ú Á¦Ç° ǰÁúÀ» º¸ÀåÇÕ´Ï´Ù.

½ÃÀåÀº ÇÁ·Î¼¼½º À¯Çü¿¡ µû¶ó ¼¼ °¡Áö ¹üÁÖ·Î ³ª´µ¾îÁ® ÀÖ½À´Ï´Ù. ¹èÄ¡ ó¸®, ¿¬¼Ó ó¸®, Æäµµ ¹èÄ¡ ó¸®ÀÔ´Ï´Ù. ¹èÄ¡ 󸮴Â, ±× °£Æí¼º°ú Á¦¾î¼ºÀ¸·ÎºÎÅÍ °è¼ÓÇØ¼­ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. Æäµµ ¹èÄ¡ 󸮴 ´õ ³ôÀº ¼öÀ² ¹× À¯¿¬¼º¿¡ ÀÇÇØ ÁöÁöµÇ°í ÀÖ½À´Ï´Ù. ¿¬¼Ó 󸮴Â, ƯÈ÷ °íµµÀÇ »ý¹° Á¦Á¦³ª ¹é½Å Á¦Á¶¿¡ ÀÖ¾î, È¿À²¼º°ú »ý»ê ½Ã°£ÀÇ ´ÜÃà¿¡ ÀÇÇØ ±â¼¼¸¦ ´õÇϰí ÀÖ½À´Ï´Ù.

¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼ú ½ÃÀå : Áö¿ªº° ºÐ¼®

¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼ú ½ÃÀåÀº ÷´Ü ¹ÙÀÌ¿À ÀǾàǰ »ê¾÷, °ß°íÇÑ ¿¬±¸ ÀÎÇÁ¶ó, FDA°¡ ÁÖµµÇÏ´Â ¾ö°ÝÇÑ ±ÔÁ¦ ȯ°æÀ¸·Î ºÏ¹Ì¸¦ ÇʵηΠ°­ÇÑ Áö¿ªÀû ´Ù¾ç¼ºÀ» º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù. ¹Ì±¹¿¡´Â È¿À²¼ºÀ» ³ôÀ̱â À§ÇØ ÀÏȸ¿ë ±â¼ú°ú ÀÚµ¿È­¸¦ ¿ì¼±½ÃÇÏ´Â ¹ÙÀÌ¿À ÇÁ·Î¼¼½º Çõ½ÅÀÇ °ÅÁ¡ÀÌ ¸¹ÀÌ Á¸ÀçÇÕ´Ï´Ù. À¯·´Àº ´ëÇü Á¦¾àȸ»çÀÇ Á¸Àç¿Í ÃÖ÷´Ü ¹ÙÀÌ¿À ÇÁ·Î¼¼½º ±â¼úÀÇ Ã¤¿ëÀ» Àå·ÁÇÏ´Â EMAÀÇ Àû±ØÀûÀÎ ±ÔÁ¦ Ʋ¿¡ ÀÇÇØ µÞ¹ÞħµÇ°í ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç Áö¿ªÀº, ¹ÙÀÌ¿À Å×Å©³î·ÎÁö Á¦Á¶ ´É·ÂÀ» °­È­ÇØ, ÀÇ·á ¾×¼¼½º¸¦ °³¼±Çϱâ À§ÇÑ Áß±¹, ÀϺ», Àεµ µîÀÇ ³ª¶ó¿¡¼­ Á¤ºÎÀÇ ´ëó¿¡ µÞ¹ÞħµÇ¸ç, ÁÖ¿ä ¼ºÀå Áö¿ªÀ¸·Î¼­ ±Þ¼ÓÈ÷ ´ëµÎÇϰí ÀÖ½À´Ï´Ù. ÇöÁöÀÇ ¹ÙÀÌ¿À °¡°ø ½Ã¼³¿¡ ´ëÇÑ ÅõÀÚ³ª, Çмú ±â°ü°ú ¾÷°è °ü°èÀÚÀÇ Çù·Â °ü°è Áõ°¡°¡, ÀÌ È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¹Ý¸é ¶óƾ¾Æ¸Þ¸®Ä«¿Í Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­´Â ¹ÙÀÌ¿À½Ã¹Ð·¯¿Í ¹é½Å »ý»êÀ» Áö¿øÇϱâ À§ÇÑ ¿ª·® ±¸Ãà°ú ÀÎÇÁ¶ó Á¤ºñ¿¡ ÁßÁ¡À» µÎ°í ÀÖ¾î ¿Ï¸¸ÇÑ »ó½Â¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼ú ½ÃÀå : °æÀï ±¸µµ

¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼ú ½ÃÀåÀº Áö¿ªÂ÷°¡ Å©°í, ºÏ¹Ì´Â È®¸³µÈ ¹ÙÀÌ¿ÀÀǾàǰ ºÐ¾ß, ±¤¹üÀ§ÇÑ ¿¬±¸°³¹ß Ȱµ¿, FDA¿¡ ÀÇÇÑ °­·ÂÇÑ ±ÔÁ¦ Áö¿ø¿¡ ÀÇÇØ ÃÖÀü¼±¿¡ ÀÖ½À´Ï´Ù. ¹Ì±¹Àº ÀÏȸ¿ë ½Ã½ºÅÛ°ú ÀÚµ¿È­ ±â¼úÀÇ Çõ½ÅÀ» °è¼Ó ¼±µµÇÏ¸ç ¹ÙÀÌ¿ÀÇÁ·Î¼¼½ºÀÇ Áøº¸¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. À¯·´Àº, ´ë±â¾÷ Á¦¾à Á¦Á¶¾÷üÀÇ Á¸Àç ¹× ±â¼ú µµÀÔÀ» ÀçÃËÇÏ´Â EMAÀÇ ¾ö°ÝÇÑ ±ÔÁ¦·ÎºÎÅÍ ÇýÅÃÀ» ¹Þ¾Æ, ±Ù¼ÒÇÑ Â÷ÀÌ·Î °æÇÕÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº, Áß±¹, Àεµ, ÀϺ» µî, ¹ÙÀÌ¿À Å×Å©³î·ÎÁö Á¦Á¶ ÀÎÇÁ¶ó ¹× ´É·ÂÀÇ È®´ë¸¦ ¸ñÇ¥·Î ÇÏ´Â ³ª¶óµéÀÇ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê¿¡ ÈûÀÔ¾î, ±Þ¼ÓÈ÷ ´ëµÎÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ³ë·ÂÀº, »ý»ê È¿À² Çâ»óÀ» À§ÇÑ ÇöÁö ±â¾÷°ú ¼¼°è ±â¾÷°úÀÇ ÆÄÆ®³Ê½ÊÀÇ È®´ë¿¡ ÀÇÇØ¼­ º¸¿ÏµÇ°í ÀÖ½À´Ï´Ù. ´ëÁ¶ÀûÀ¸·Î, ¶óƾ ¾Æ¸Þ¸®Ä«³ª Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« µîÀÇ Áö¿ªÀº, »ý¹° Á¦Á¦ ¹× ¹ÙÀÌ¿À½Ã¹Ð·¯ÀÇ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ, ÀÎÇÁ¶ó °­È­¿Í ±â¼ú ÀÌÀü¿¡ ÁßÁ¡À» µÎ¸é¼­, ¹ÙÀÌ¿ÀÇÁ·Î¼¼½ºÀÇ ¿¡ÄÚ ½Ã½ºÅÛÀ» ¼­¼­È÷ ¹ßÀü½Ã۰í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼ú ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼úÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼ú ½ÃÀå : »ê¾÷ ºÐ¼®

Á¦5Àå ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼ú ½ÃÀå : ³ô¾ÆÁö´Â ÁöÁ¤ÇÐÀû ±äÀåÀÇ ¿µÇâ

Á¦6Àå ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼ú ½ÃÀå »óȲ

Á¦7Àå ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼ú ½ÃÀå : Á¦Ç° À¯Çüº°

Á¦8Àå ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼ú ½ÃÀå : ÇÁ·Î¼¼½º À¯Çüº°

Á¦9Àå ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼ú ½ÃÀå : ¼¼Æ÷ À¯Çüº°

Á¦10Àå ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼ú ½ÃÀå : ±Ô¸ðº°

Á¦11Àå ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼ú ½ÃÀå : ¿ëµµº°

Á¦12Àå ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼ú ½ÃÀå : Áö¿ªº°

Á¦13Àå ÁÖ¿ä º¥´õ ºÐ¼® : ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼ú ¾÷°è

Á¦14Àå AnalystViewÀÇ Àü¹æÀ§ ºÐ¼®

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Bioprocess Technology Market size was valued at US$ 30,710.32 Million in 2024, expanding at a CAGR of 14.90% from 2025 to 2032.

The Bioprocess Technology Market encompasses the tools, equipment, and techniques used to develop and manufacture biological products, including vaccines, monoclonal antibodies, and cell therapies. Growth in this market is fueled by rising demand for biologics, increasing investments in personalized medicine, and advancements in single-use technologies that enhance flexibility and reduce contamination risks. In 2023, over 60% of biopharmaceutical manufacturers globally had adopted single-use bioreactors to streamline production processes. However, high initial costs and complexity in scaling up processes remain significant challenges. Opportunities lie in the integration of automation, AI-driven process optimization, and continuous bioprocessing, which promise to improve efficiency and product consistency while reducing time to market. Additionally, expanding research in emerging regions like Asia-Pacific offers substantial growth potential as local manufacturers modernize their bioprocessing capabilities.

Bioprocess Technology Market- Market Dynamics

Advancements in single-use and automation technologies to accelerate market growth

Advancements in single-use and automation technologies are transforming bioprocessing, with organizations such as the FDA and NIH emphasizing their role in enhancing manufacturing flexibility and reducing contamination risks. The FDA's 2022 guidelines highlight single-use systems as a critical component in modern biologics production, supporting rapid scale-up and minimizing cross-contamination. According to a report by the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), automated bioprocessing platforms can reduce production cycle times by up to 30%, increasing efficiency and consistency. Moreover, continuous bioprocessing techniques endorsed by regulatory bodies are gaining traction, especially in vaccine manufacturing, allowing faster responses to public health emergencies. These technological shifts are particularly impactful in regions like the U.S. and Europe, where stringent quality standards drive adoption, while emerging markets are beginning to integrate these innovations to boost local biologics manufacturing capabilities.

Bioprocess Technology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.90% over the forecast period (2025-2032)

Based on product type segmentation, Instruments was predicted to show maximum market share in the year 2024

Based on Process Type segmentation, Batch processing was the leading Process Type in 2024

Based on Cell Type segmentation, Mammalian Cells were the leading Cell Type in 2024

Based on Scale segmentation, Commercial-Scale was the leading Scale in 2024

Based on Application segmentation, Monoclonal Antibody Production was the leading Application in 2024

On the basis of region, North America was the leading revenue generator in 2024

Bioprocess Technology Market- Segmentation Analysis:

The Global Bioprocess Technology Market is segmented on the basis of Product Type, Process Type, Cell Type, Scale, Application, and Region.

The market is divided into two categories based on product type: Instruments (Bioprocess Analyzers, Gas Analyzers, Osmometers, Cell Counter Systems, Bioreactors, and Incubators) and Consumables & Accessories (Culture Media and Reagents). Instruments dominate due to their critical role in process control and monitoring, with bioreactors and bioprocess analyzers leading demand; consumables and accessories, including culture media and reagents, support daily operations and ensure consistent cell growth and product quality in bioprocessing workflows.

The market is divided into three categories based on Process Type: Batch Processing, Continuous Processing, and Fed-Batch Processing. Batch processing remains widely used for its simplicity and control; fed-batch processing is favored for higher yields and flexibility; continuous processing is gaining momentum due to efficiency and reduced production times, especially in advanced biologics and vaccine manufacturing.

Bioprocess Technology Market- Geographical Insights

The Bioprocess Technology Market exhibits strong regional diversity, with North America leading due to its advanced biopharmaceutical industry, robust research infrastructure, and stringent regulatory environment led by the FDA. The U.S. houses numerous bioprocessing innovation hubs that prioritize single-use technologies and automation to enhance efficiency. Europe follows closely, supported by the presence of major pharmaceutical companies and proactive regulatory frameworks from the EMA that encourage the adoption of cutting-edge bioprocessing techniques. The Asia-Pacific region is rapidly emerging as a key growth area, driven by government initiatives in countries like China, Japan, and India to strengthen biotech manufacturing capabilities and improve healthcare access. Investments in local bioprocessing facilities and increasing collaborations between academic institutions and industry players fuel this expansion. Meanwhile, Latin America and the Middle East & Africa are witnessing a gradual uptake, with a growing focus on capacity building and infrastructure development to support the production of biosimilars and vaccines.

Bioprocess Technology Market- Competitive Landscape:

The Bioprocess Technology Market shows significant regional variation, with North America at the forefront due to its well-established biopharmaceutical sector, extensive R&D activities, and strong regulatory support from the FDA. The U.S. continues to lead innovation in single-use systems and automation technologies, driving bioprocess advancements. Europe is a close contender, benefiting from the presence of major pharmaceutical manufacturers and stringent regulations from the EMA that encourage technology adoption. Asia-Pacific is emerging rapidly, supported by government initiatives in countries such as China, India, and Japan aimed at expanding biotech manufacturing infrastructure and capabilities. These efforts are complemented by growing partnerships between local companies and global players to improve production efficiency. In contrast, regions like Latin America and the Middle East & Africa are gradually developing their bioprocessing ecosystems, focusing on infrastructure enhancement and technology transfer to meet increasing demand for biologics and biosimilars.

Recent Developments:

In October 2022, PharmNXT Biotech launched its first integrated manufacturing unit for single-use bioprocessing systems in Chakan, Pune, offering state-of-the-art solutions for biologics manufacturing and aiming to serve both Indian and global markets.

In October 2023, Tetra Pak and Lund University launched Biotech Heights, a new research hub in Sweden focused on advancing bioprocessing technologies for sustainable food and material production, fostering open innovation and collaboration between academia and industry.

In July 2024, Nirrin Technologies launched the Atlas system, enabling at-line analysis of buffer components and product titer in one minute using high-precision tunable laser spectroscopy, providing rapid, actionable data for improved bioprocess control in biopharmaceutical manufacturing.

In April 2025, Asahi Kasei Bioprocess America won the Best Technologies Innovation Award at INTERPHEX 2025 for its THESYS C&D/TFF unit, an integrated, automated system that streamlines oligonucleotide manufacturing, boosting efficiency and throughput for advanced therapeutic production.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOPROCESS TECHNOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY PROCESS TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY CELL TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY SCALE- MARKET ANALYSIS, 2019 - 2032

GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Bioprocess Technology Market Overview

2. Executive Summary

3. Bioprocess Technology Key Market Trends

4. Bioprocess Technology Industry Study

5. Bioprocess Technology Market: Impact of Escalating Geopolitical Tensions

6. Bioprocess Technology Market Landscape

7. Bioprocess Technology Market - By Product Type

8. Bioprocess Technology Market - By Process Type

9. Bioprocess Technology Market - By Cell Type

10. Bioprocess Technology Market - By Scale

11. Bioprocess Technology Market - By Application

12. Bioprocess Technology Market- By Geography

13. Key Vendor Analysis- Bioprocess Technology Industry

14. 360 Degree Analyst View

15. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â